EcoDrugPlus

Dopamine Receptor D4b

Ensembl ID : ENSAMXG00000029361
Gene Symbol: DRD4B
1 Cross references
176 Possible Orthologues:

Ectonucleotide Pyrophosphatase/phosphodiesterase 2

Ensembl ID : ENSAMXG00000031220
Gene Symbol: ENPP2
3 Cross references
226 Possible Orthologues:

Egl Nine Homolog 1-Like

Ensembl ID : ENSAMXG00000029242
Gene Symbol: LOC103047661
2 Cross references
189 Possible Orthologues:

Egl-9 Family Hypoxia Inducible Factor 3

Ensembl ID : ENSAMXG00000002702
Gene Symbol: EGLN3
3 Cross references
203 Possible Orthologues:

Endothelial Pas Domain Protein 1

Ensembl ID : ENSAMXG00000000017
Gene Symbol: EPAS1
3 Cross references
153 Possible Orthologues:

Endothelial Pas Domain Protein 1b

Ensembl ID : ENSAMXG00000004315
Gene Symbol: EPAS1B
1 Cross references
214 Possible Orthologues:

Endothelin Converting Enzyme 1

Ensembl ID : ENSAMXG00000031542
Gene Symbol: ECE1
1 Cross references
231 Possible Orthologues:

Endothelin Receptor Ba

Ensembl ID : ENSAMXG00000036587
Gene Symbol: EDNRBA
1 Cross references
156 Possible Orthologues:

Endothelin Receptor Type B

Ensembl ID : ENSAMXG00000001844
Gene Symbol: EDNRB
3 Cross references
200 Possible Orthologues:

Endothelin-1 Receptor-Like

Ensembl ID : ENSAMXG00000035645
Gene Symbol: LOC107197257
3 Cross references
201 Possible Orthologues:

Enhancer Of Zeste 2 Polycomb Repressive Complex 2 Subunit

Ensembl ID : ENSAMXG00000021485
Gene Symbol: EZH2
3 Cross references
240 Possible Orthologues:

Eph Receptor B4b

Ensembl ID : ENSAMXG00000019985
Gene Symbol: EPHB4B
1 Cross references
170 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).